NASDAQ · Medical - Care Facilities

AIRS (AIRS) Stock

$2.46 +1.44% NASDAQ: AIRS Healthcare

Valuation

MetricValue
Price$2.46
Market Cap$173.54M
P/E Ratio-26.47
P/B Ratio4.03
P/S Ratio2.36
EPS (TTM)$-0.19
52-Week High$12.00
52-Week Low$1.51
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-13.64%
ROA-6.42%
ROCE-5.75%
Gross Margin-3.29%
Operating Margin-3.29%
Net Margin-7.39%
Debt/Equity0.71
Current Ratio0.54

Annual Financials (USD)

Metric20212022202320242025
Revenue$133.0M$169.0M$196.0M$180.0M$152.0M
Operating Profit$16.0M$-5.0M$9.0M$-2.0M$-5.0M
Net Profit$11.0M$-15.0M$-4.0M$-8.0M$-12.0M
EPS$-0.01$-0.26$-0.08$-0.14$-0.19
Op Margin11.8%-2.7%4.8%-1.0%-3.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$201.0M$201.0M$204.0M$210.0M$187.0M
Total Liabilities$117.0M$130.0M$120.0M$131.0M$100.0M
Cash$25.0M$10.0M$10.0M$8.0M$8.0M
Borrowings$101.0M$108.0M$100.0M$105.0M$84.0M

Latest News

AirSculpt Technologies Announces Participation in Upcoming Investor Conferences GlobeNewswire · May 27, 2026 AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth MarketBeat · May 19, 2026 AirSculpt Technologies Q1 Earnings Call Highlights MarketBeat · May 8, 2026 AirSculpt Technologies Reports First Quarter Fiscal 2026 Results GlobeNewswire · May 8, 2026 AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results GlobeNewswire · May 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$27.0M$24.0M$24.0M$11.0M$3.0M
Investing Cash Flow$-14.0M$-26.0M$-20.0M$-28.0M$-5.0M
Financing Cash Flow$0$-2.0M$-1.0M$-2.0M$0
Net Cash Flow$15.0M$-16.0M$1.0M$-2.0M$0
Free Cash Flow$20.0M$12.0M$14.0M$-3.0M$1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA53.81
FCF Yield1.93%
Quick Ratio0.75
Interest Coverage-0.83
Return 1Y-27.60%
Return 3Y-45.06%
Return 5Y—

Ownership

Insiders Held43.06%
Institutions Held66.03%
Institutions Float Held115.98%
Institutional HolderSharesReport Date
Vesey Street Capital Partners, LLC30,324,1802026-03-31
Balyasny Asset Management LP2,326,6902026-03-31
FourWorld Capital Management, LLC987,7572026-03-31
Blackrock Inc.804,0792026-03-31
Wexford Capital LP670,5172026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMN $33.38 -0.48% -11.68 $1.29B 0.00%
AQST $5.38 +2.67% -8.29 $675.01M 0.00%
CMPSCOMPASS Pathways plc $13.31 -0.60% -6.19 $1.28B 0.00%
CYH $2.90 -1.02% -1.28 $408.93M 0.00%
DRIO $7.30 +3.99% -10.51 $53.38M 0.00%

About AIRS

AIRS is led by CEO Yogesh Jashnani, employs 389 people, headquartered in US, publicly traded since 2021.

AIRS stock trades at $2.46 with a market capitalization of $173.54M. The stock is valued at a price-to-earnings (P/E) ratio of -26.47, price-to-book of 4.03, price-to-sales of 2.36. Over the past 52 weeks the stock has ranged between $1.51 and $12.00, and currently trades 79.5% below its 52-week high.

On profitability, AIRS generates a return on equity (ROE) of -13.64%, return on capital employed of -5.75%, an operating margin of -3.29%, a net profit margin of -7.39%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides